Eikon Therapeutics, Inc. Common Stock

Total Valuation

Eikon Therapeutics, Inc. Common Stock carries a market capitalization of 447.46M, placing it among publicly traded companies globally. Its enterprise value stands at 427.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Eikon Therapeutics, Inc. Common Stock currently has 54.15M shares outstanding.

Valuation Ratios

Financial Position

Eikon Therapeutics, Inc. Common Stock maintains a current ratio of 9.89, meaning it holds 9.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 54.07, indicating elevated leverage, while an interest coverage ratio of 6,605.77 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Eikon Therapeutics, Inc. Common Stock's stock has declined approximately -44.9% over the past 52 weeks. The 50-day moving average sits at 9.34, while the 200-day moving average is 10.63.

Income Statement

EBITDA reached -317.08M, while operating income came in at -338.65M.

Balance Sheet

Eikon Therapeutics, Inc. Common Stock holds 531.18M in cash and equivalents against 252.22M in total debt, resulting in a net debt position of -142.61M. Total book value stands at 466.50M, with working capital of 491.68M providing operational flexibility.

Cash Flow

Eikon Therapeutics, Inc. Common Stock produced -256.02M in operating cash flow over the past twelve months. After subtracting -3.18M in capital expenditures, free cash flow totaled -259.20M - equivalent to -5.90 per share.

Dividends & Yields

Scores

Eikon Therapeutics, Inc. Common Stock posts an Altman Z-Score of -1.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.